Overview Fundamentals API Earnings EOD API Sample Code Pricing

PolyPid (PYPD NASDAQ) stock market data APIs

$3.71 -0.05(-1.3%) as of July 16, 2024
Price chart is built with Anychart

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

PolyPid Financial Data Overview

18 038 K
4 797 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'PYPD',
Type: 'Common Stock',
Name: 'PolyPid',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG002Q6KV39',
ISIN: 'IL0011326795',
CIK: '1611842',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2020-06-26',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,

PolyPid Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -21 532 750
  • Earnings Per Share -9.89
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get PolyPid Earnings via APIs

  • Latest Release 2024-05-08
  • EPS/Forecast -1.41

Get PolyPid End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?